Kerna Ventures
VC Fund
Kerna Ventures is an early-stage venture capital firm that invests in advanced therapeutic platform technologies, focusing on genome engineering, cell reprogramming, and computational biology. Kerna Ventures typically invests in seed through Series A funding rounds, with ticket sizes ranging from $0.5 million to $5 million.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Kerna Ventures invests in
Stages Kerna Ventures invests in
Countries Kerna Ventures invests in
Investment Focus
Industry
- Biotechnology 3 (100%)
- Biopharma 1 (33%)
- Life Science 1 (33%)
- Therapeutics 1 (33%)
Stage
- Seed 2 (67%)
- Series C 1 (33%)
Country
- United States 2 (67%)
- Ireland 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Vivere develops targeted cancer therapies that activate the immune system to detect and destroy tumors using engineered bio-platforms. | $10M / Seed / Jan 13, 2026 | ||
| Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain disorders. | $21M / Seed / Oct 01, 2025 | ||
| Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases. The company utilizes artificial intelligence and high-throughput screening to discover and optimize novel gene-editing systems. Its research focuses on expanding the CRISPR-based gene editing toolbox for therapeuticapplications. Arbor aims to develop treatments for rare and complex diseases by engineering precise and efficient genetic modifications. | $73.9M / Series C / Mar 18, 2025 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Kerna Ventures invest in?
Kerna Ventures invests primarily in Biotechnology, Biopharma and Life Science startups, most often at Seed and Series C stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Kerna Ventures last invest?
The most recent investment recorded for Kerna Ventures closed in Jan 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
